(Q44881887)

7 December 2017

title

Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis (English)

1 reference

7 December 2017

8

Paul Rutgeerts

1 reference

7 December 2017

Gary Toedter

1

1 reference

7 December 2017

Katherine Li

2

1 reference

7 December 2017

Colleen Marano

3

1 reference

7 December 2017

Keying Ma

4

1 reference

7 December 2017

Sarah Sague

5

1 reference

7 December 2017

C Chris Huang

6

1 reference

7 December 2017

Xiao-Yu Song

7

1 reference

7 December 2017

Frédéric Baribaud

9

1 reference

7 December 2017

language of work or name

English

0 references

publication date

29 March 2011

1 reference

The American Journal of Gastroenterology

7 December 2017

published in

1 reference

7 December 2017

volume

106

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1272-1280

1 reference

Inflammatory bowel disease: cause and immunobiology

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Inflammatory bowel disease: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Mucosal cytokine network in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Importance of mucosal healing in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Defects in mucosal immunity leading to ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

The IL23 axis plays a key role in the pathogenesis of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Interleukin-23 and Th17 cells in the control of gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

The role of the novel Th17 cytokine IL-26 in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.83

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.83

1 reference

7 December 2017

1 reference